March 2026 | New Delhi, India
The FE Pharma Summit & Awards 2026, hosted by The Financial Express, brought together some of India’s leading pharmaceutical minds this March, and DDReg Pharma walked away with one of its standout recognitions: Excellence in Pharma Service Company of the Year.
The award reflects the work DDReg has been quietly building over the years, helping pharmaceutical, biotechnology, and healthcare companies navigate the often demanding terrain of global regulatory submissions, pharmacovigilance, and market access. It is the kind of recognition that speaks less to a single achievement and more to a sustained direction.
At the core of DDReg’s offering is a team of regulatory affairs specialists and scientific advisors working across multiple geographies, supporting submissions to health authorities worldwide. More recently, the company has channelled efforts into Vitalic, its regulatory technology platform built to streamline lifecycle tracking and regulatory intelligence, reflecting a broader shift in how the industry thinks about compliance and submission efficiency.
Neeraj Pant, Co-founder & Executive Director, noted that the recognition underscores the company’s focus on helping clients find their footing in increasingly complex regulatory environments. This challenge is only expected to grow as digitisation, real-world evidence, and new therapeutic categories continue to reshape the landscape.
For DDReg, the acknowledgement is a marker on a longer journey, one centred on making the path to market faster and more navigable for the companies it works with.
About DDReg
DDReg Pharma is a global life science consulting firm, supporting pharmaceutical, biotech, and medical device companies across the product lifecycle. With deep scientific expertise and digital innovation, DDReg empowers clients to meet compliance requirements and accelerate market access worldwide.